Samsung imports 1 million LDS syringes to support India's COVID-19 vaccination drive

Updated:4 months ago

New Delhi, May 27 (ANI): South Korean tech giant Samsung is importing one million innovative Low Dead Space (LDS) syringes in a bid to support India's COVID-19 vaccination drive. This is part of the company's COVID Support programme for the country.LDS syringes minimise the amount of drug left in the syringes after an injection, reducing vaccine wastage, and thereby enabling 20 per cent more people to get the dose with the same amount of vaccine.LDS syringes, airlifted from South Korea, have been delivered to Uttar Pradesh - 325,000 each to the district administrations in Lucknow and Noida - while 350,000 LDS syringes will soon be handed over to the Greater Chennai Corporation in Tamil Nadu. These syringes will be deployed at COVID vaccination centres in the districts. The technology behind LDS syringes has demonstrated up to 20 per cent greater efficiency. That means if existing syringes were to deliver one million doses, LDS syringes could deliver 1.2 million doses with the same amount of vaccine. Samsung has helped the manufacturer of these syringes increase production capacity.

Related Video